Gut microbes and untargeted/targeted metabolomics were combined to comprehensively understand the therapeutic effect and the underlying mechanism of Lycium barbarum arabinogalactan (LBP-3) in DSS-induced colitis mice.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: